Jenburkt Pharmaceuticals (BOM:524731) 3-Year EBITDA Growth Rate : 17.70% (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Jenburkt Pharmaceuticals 3-Year EBITDA Growth Rate?

Jenburkt Pharmaceuticals's EBITDA per Share for the three months ended in Mar. 2024 was ₹25.02.

During the past 12 months, Jenburkt Pharmaceuticals's average EBITDA Per Share Growth Rate was 10.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 17.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 9.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Jenburkt Pharmaceuticals was 39.20% per year. The lowest was -3.80% per year. And the median was 15.50% per year.

Competitive Comparison of Jenburkt Pharmaceuticals's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Jenburkt Pharmaceuticals's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jenburkt Pharmaceuticals's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jenburkt Pharmaceuticals's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Jenburkt Pharmaceuticals's 3-Year EBITDA Growth Rate falls into.

Jenburkt Pharmaceuticals 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Jenburkt Pharmaceuticals (BOM:524731) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Jenburkt Pharmaceuticals 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Jenburkt Pharmaceuticals's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Jenburkt Pharmaceuticals (BOM:524731) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jenburkt Pharmaceuticals Ltd (BOM:524731) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

93, Jayprakash Road, Nirmala Apartments, Andheri (West), Mumbai, MH, IND, 400058

Website

https://www.jenburkt.com

Jenburkt Pharmaceuticals Ltd is engaged in the manufacturing, producing, developing, and marketing of pharmaceutical formulations. The company operates in one segment - pharmaceutical formulations. The company generates key revenue from the local market.

Jenburkt Pharmaceuticals (BOM:524731) Headlines

No Headlines